Stella Diagnostics (Stella Diagnostics) Equity-to-Asset : -37.24 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Stella Diagnostics's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $-16.42 Mil. Stella Diagnostics's Total Assets for the quarter that ended in Sep. 2023 was $0.44 Mil.

The historical rank and industry rank for Stella Diagnostics's Equity-to-Asset or its related term are showing as below:

SLDX' s Equity-to-Asset Range Over the Past 10 Years
Min: -37.24 Med: -37.24 Max: -37.24
Current: -37.24

During the past 0 years, the highest Equity to Asset Ratio of Stella Diagnostics was -37.24. The lowest was -37.24. And the median was -37.24.

SLDX's Equity-to-Asset is ranked worse than
99.57% of 235 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.59 vs SLDX: -37.24

Stella Diagnostics Equity-to-Asset Historical Data

The historical data trend for Stella Diagnostics's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Equity-to-Asset Chart

Stella Diagnostics Annual Data

Trend

Equity-to-Asset

Stella Diagnostics Quarterly Data
	Sep22	Sep23
Equity-to-Asset	-	-37.24

Competitive Comparison of Stella Diagnostics's Equity-to-Asset

For the Diagnostics & Research subindustry, Stella Diagnostics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stella Diagnostics's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Stella Diagnostics's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Stella Diagnostics's Equity-to-Asset falls into.

Stella Diagnostics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Stella Diagnostics's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )	=	Total Stockholders Equity	/	Total Assets
	=		/
	=

Stella Diagnostics's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	-16.422	/	0.441
	=

Stella Diagnostics (OTCPK:SLDX) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Stella Diagnostics Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.